STADA Pharmaceuticals (Beijing) Limited
In May 2005 Stada Beijing was established through acquisition of Beijing Center-Lab Pharmaceutical Company Ltd. (BCP). STADA Beijing is located in the Economical Development Zone of Miyun, Beijing, covering an area of 13,258 M2, having GMP standard equipment and facility for 11 products represented by Shidagong and Ruike, which belong to the dosage forms of syrup, oral solution, suspension, etc. By upholding the fine tradition and adhering to the principle of “quality first, strict management, continuous innovation”, STADA Beijing has been committed to providing safe and effective products in excellent quality. Now STADA Beijing is currently focusing on implement OpEx management to expand production capacity and improve OEE level. Built a strong sales organization in the major cities of China with a commercial network, Annual sales （2019）reached RMB 187.7m.